10.50Open10.50Pre Close0 Volume36 Open Interest40.00Strike Price0.00Turnover74.66%IV12.98%PremiumAug 16, 2024Expiry Date4.70Intrinsic Value100Multiplier24DDays to Expiry5.80Extrinsic Value100Contract SizeAmericanOptions Type0.7537Delta0.0362Gamma7.15Leverage Ratio-0.0596Theta0.0187Rho5.39Eff Leverage0.0368Vega
MoonLake Immunotherapeutics Stock Discussion
$Leap Therapeutics(LPTX.US)$ Phase 2
$Vera Therapeutics(VERA.US)$ Phase 2b
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$Akero Therapeutics(AKRO.US)$ Phase 2b
$Spruce Biosciences(SPRB.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$Annexon(ANNX.US)$ Phase 2a
$Roivant Sciences(ROIV.US)$...
$Regenxbio(RGNX.US)$ Phase 2
$Leap Therapeutics(LPTX.US)$ Phase 2
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals(EYPT.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US)$ Phase 2
$Disc Medicine(IRON.US)$ Phase 2
$Atea Pharmaceuticals(AVIR.US)$ Phase 2
$Allakos(ALLK.US)$ Phase 2 ...
The short stock would be $MoonLake Immunotherapeutics(MLTX.US)$ It has just seen its highest run. Once it gets above 50.00 its loses investors interest.
No comment yet